FI920717A0 - Fosfolipid- eller lipidbundna glykosaminoglykan, foerfarande foer dess framstaellning och metastasinhibitor. - Google Patents

Fosfolipid- eller lipidbundna glykosaminoglykan, foerfarande foer dess framstaellning och metastasinhibitor.

Info

Publication number
FI920717A0
FI920717A0 FI920717A FI920717A FI920717A0 FI 920717 A0 FI920717 A0 FI 920717A0 FI 920717 A FI920717 A FI 920717A FI 920717 A FI920717 A FI 920717A FI 920717 A0 FI920717 A0 FI 920717A0
Authority
FI
Finland
Prior art keywords
phospholipid
derivative
glycosaminoglycan
metastasinhibitor
lipidbundna
Prior art date
Application number
FI920717A
Other languages
English (en)
Other versions
FI103279B (fi
FI103279B1 (fi
Inventor
Katsukiyo Sakurai
Nobuo Sugiura
Koji Kimata
Sakaru Suzuki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2193816A external-priority patent/JP2986518B2/ja
Priority claimed from JP2193817A external-priority patent/JP2997018B2/ja
Priority claimed from JP2193818A external-priority patent/JP2986519B2/ja
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of FI920717A0 publication Critical patent/FI920717A0/fi
Application granted granted Critical
Publication of FI103279B publication Critical patent/FI103279B/fi
Publication of FI103279B1 publication Critical patent/FI103279B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI920717A 1990-07-24 1992-02-19 Menetelmä terapeuttisesti käyttökelpoisten fosfolipidi- tai lipidiliitteisten glykosaminoglykaaniyhdisteiden valmistamiseksi FI103279B1 (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP19381690 1990-07-24
JP19381890 1990-07-24
JP2193816A JP2986518B2 (ja) 1990-07-24 1990-07-24 癌転移抑制剤
JP2193817A JP2997018B2 (ja) 1990-07-24 1990-07-24 燐脂質又は脂質結合グリコサミノグリカン
JP19381790 1990-07-24
JP2193818A JP2986519B2 (ja) 1990-07-24 1990-07-24 燐脂質結合グリコサミノグリカン
JP9100995 1991-07-24
PCT/JP1991/000995 WO1992001720A1 (en) 1990-07-24 1991-07-24 Phospholipid- or lipid-combining glycosaminoglycan, production thereof, and cancer metastasis inhibitor

Publications (3)

Publication Number Publication Date
FI920717A0 true FI920717A0 (fi) 1992-02-19
FI103279B FI103279B (fi) 1999-05-31
FI103279B1 FI103279B1 (fi) 1999-05-31

Family

ID=27326820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920717A FI103279B1 (fi) 1990-07-24 1992-02-19 Menetelmä terapeuttisesti käyttökelpoisten fosfolipidi- tai lipidiliitteisten glykosaminoglykaaniyhdisteiden valmistamiseksi

Country Status (10)

Country Link
US (1) US5464942A (fi)
EP (1) EP0493622B1 (fi)
KR (1) KR0181295B1 (fi)
AT (1) ATE148713T1 (fi)
AU (1) AU647814B2 (fi)
CA (1) CA2067211C (fi)
DE (1) DE69124590T2 (fi)
FI (1) FI103279B1 (fi)
NO (1) NO305368B1 (fi)
WO (1) WO1992001720A1 (fi)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
KR20030097604A (ko) * 1992-07-13 2003-12-31 유카리언, 인코포레이티드 세포의 세포내 구획으로 지질화된 면역글로불린을전달하기 위한 조성물, 지질화된 단백질 및 지질화된 항체
JP3714683B2 (ja) * 1992-07-30 2005-11-09 生化学工業株式会社 抗リウマチ剤
JP2787279B2 (ja) * 1994-05-17 1998-08-13 雪印乳業株式会社 糖リン脂質及びその調製法
US6228998B1 (en) 1994-07-22 2001-05-08 Seikagaku Kogyo Kabushiki Kaisha Amino spacered glycosaminoglycan derivatives and their use in copolymerization with acrylamide
FR2725622A1 (fr) * 1994-10-14 1996-04-19 Fabre Pierre Dermo Cosmetique Ceramide greffee anti-elastase
CA2175282A1 (en) * 1996-04-29 1997-10-30 Rudolf Edgar Falk Use of forms of hyaluronic acid (ha) for the treatment of cancer
WO2000040253A1 (en) * 1999-01-08 2000-07-13 The Board Of Trustees Of The University Of Arkansas Synthetic, highly charged molecules and uses thereof
JP3032824B1 (ja) * 1999-01-28 2000-04-17 東京医科歯科大学長 骨誘導促進剤
JP4754137B2 (ja) * 1999-08-10 2011-08-24 生化学工業株式会社 グリコサミノグリカン誘導体およびその使用
US8916539B2 (en) * 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US8076312B2 (en) * 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US9040078B2 (en) * 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US20090325876A1 (en) * 2004-09-29 2009-12-31 Saul Yedgar Use of lipid conjugates in the treatment of diseases associated with vasculature
US7811999B2 (en) * 2000-01-10 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US8501701B2 (en) * 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
US8304395B2 (en) * 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US7393938B2 (en) * 2000-01-10 2008-07-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US7772196B2 (en) * 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US20060189570A1 (en) * 2000-01-10 2006-08-24 Saul Yedgar Use of lipid conjugates in the treatment of infection
US7101859B2 (en) * 2000-01-10 2006-09-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
US8883761B2 (en) * 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
US7280612B2 (en) * 2003-07-25 2007-10-09 Zarbana Digital Fund Llc Digital branch calibrator for an RF transmitter
EP1681306B1 (en) * 2003-10-29 2013-02-20 Teijin Limited Hyaluronic acid compound, hydrogel thereof and material for treating joint
CN104546891A (zh) * 2005-08-03 2015-04-29 塞尔索斯治疗公司 脂质结合物在囊性纤维化病中的用途及其应用
JP4744973B2 (ja) * 2005-08-05 2011-08-10 株式会社トプコン 眼底カメラ
US8475694B2 (en) 2005-10-25 2013-07-02 Zephyros, Inc. Shaped expandable material
US20110130555A1 (en) * 2009-05-11 2011-06-02 Saul Yedgar Lipid-polymer conjugates, their preparation and uses thereof
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
US20080183282A1 (en) * 2006-03-09 2008-07-31 Saul Yedgar Use of lipid conjugates for the coating of stents and catheters
WO2008059502A2 (en) * 2006-11-14 2008-05-22 Yissum Research Development Company Contact lens compositions
CA2705785A1 (en) * 2006-11-14 2008-05-22 Saul Yedgar Use of lipid conjugates in the treatment of diseases or disorders of the eye
GB0916205D0 (en) 2009-09-15 2009-10-28 Zephyros Inc Improvements in or relating to cavity filling
EP2547342A2 (en) * 2010-03-17 2013-01-23 KTB Tumorforschungsgesellschaft mbH Combined use of phospholipid and sulfate groups-carrying polysaccharides for inhibiting metastatic spread
CA2703532C (en) * 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
EP3962961A1 (en) * 2019-04-29 2022-03-09 Bausch & Lomb Incorporated Glycophospholipid polymeric network and use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
FR2492259A1 (fr) * 1980-10-21 1982-04-23 Idinvex Sa Formulation d'heparine
US4362737A (en) * 1981-04-13 1982-12-07 Schaefer Rolf Transdermal carrier materials
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4654327A (en) * 1982-04-21 1987-03-31 Research Corp. Quaternary ammonium complexes of heparin
EP0114589B1 (en) * 1982-12-20 1987-09-23 The President And Fellows Of Harvard College Inhibition of angiogenesis
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US5122450A (en) * 1985-10-24 1992-06-16 Research Corporation Limited Biochemical reagent
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
WO1989008499A1 (en) * 1988-03-17 1989-09-21 Nippon Fine Chemical Co., Ltd. Liposome
JPH0219393A (ja) * 1988-07-08 1990-01-23 Higeta Shoyu Kk Ｎ‐アセチルガラクトサミノオリゴ糖及びその製造方法
JPH0258501A (ja) * 1988-08-25 1990-02-27 Mitsubishi Gas Chem Co Inc リポ多糖およびその用途
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体

Also Published As

Publication number Publication date
KR0181295B1 (ko) 1999-04-01
EP0493622A4 (en) 1993-10-27
US5464942A (en) 1995-11-07
ATE148713T1 (de) 1997-02-15
NO305368B1 (no) 1999-05-18
EP0493622B1 (en) 1997-02-05
NO921083D0 (no) 1992-03-19
CA2067211C (en) 2004-06-15
WO1992001720A1 (en) 1992-02-06
FI103279B (fi) 1999-05-31
EP0493622A1 (en) 1992-07-08
CA2067211A1 (en) 1992-01-25
KR920702377A (ko) 1992-09-03
AU8226691A (en) 1992-02-18
DE69124590D1 (de) 1997-03-20
DE69124590T2 (de) 1997-06-12
FI103279B1 (fi) 1999-05-31
AU647814B2 (en) 1994-03-31
NO921083L (no) 1992-05-21

Similar Documents

Publication Publication Date Title
FI920717A0 (fi) Fosfolipid- eller lipidbundna glykosaminoglykan, foerfarande foer dess framstaellning och metastasinhibitor.
IE873467L (en) Aryloxy and arylacyloxymethyl aminomethylketones
ES2186013T3 (es) Nitratos organicos con actividad antitrombotica.
DK0839798T3 (da) Mellemforbindelser til at fremstille retrovirale-proteaseinhibitorer
DK0747393T3 (da) Dobbeltvirkende inhibitorer indeholdende en thiazolobenzazepinstruktur
DE3580124D1 (de) Pyridobenzothiazinderivate mit hoch antimikrobieller wirkung.
YU58298A (sh) POSTUPAK ZA PROIZVODNJU ESTARA α-TOKOFEROLA
AU7132281A (en) A non-toxic anthelmintic pour-on composition
FI884345A (fi) Sackaridderivat.
FI914526A (fi) Foerening, dess framstaellning och anvaendning.
TR200000196T2 (tr) Avermektin bileşiklerinin üretimi.
ES2093838T3 (es) Inhibidor de fosfolipasa a2.
NO913768D0 (no) Forbindelse, anvendelse og fremstilling.
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості
ES8307209A1 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
AR246965A1 (es) Procedimiento para fabricar un derivado del acido 1-3-dioxan-alquenoico.
ATE14125T1 (de) 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro-2oxo-1h-imidazol-4-carbonsaeure-derivate.
ITMI931808A1 (it) Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico
ES2055769T3 (es) Agentes pesticidas a base de derivados de la pirimidina 2-halogeno-alquiltio-substituidos.
JPS5481298A (en) Preparation of pyridopyrimidinecarboxylic acid derivative
KR900011776A (ko) 페니실린산 및 세팔로스포린산 유도체
ATE112781T1 (de) Polyglukosiden aus hydroxyalkylsorbit.
TH2674EX (th) อนุพันธุ์อินิโนเมทธิล-อาโซลิล
FR2305129A1 (fr) Composition insecticide et acaricide a base d'un carbodiimide
FR2252088A1 (en) Antibacterial 1,2,4-triazin-5-ones - of varying activity, some with tranquillizing activity